12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zonegran zonisamide regulatory update

Eisai said the European Commission approved a label extension for Zonegran zonisamide from Eisai to include monotherapy in newly diagnosed epilepsy patients with partial seizures, with and without second generalization. Separately, Eisai said EMA...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >